Literature DB >> 21452273

Incidence of arthritis in a prospective cohort of psoriasis patients.

Lihi Eder1, Vinod Chandran, Hua Shen, Richard J Cook, Sutha Shanmugarajah, Cheryl F Rosen, Dafna D Gladman.   

Abstract

OBJECTIVE: Epidemiologic studies about the incidence of psoriatic arthritis (PsA) are limited to a few population-based studies. There are limited data regarding the incidence of PsA in patients with psoriasis. We aimed to determine the incidence of PsA among a prospective cohort of psoriasis patients.
METHODS: The setting is a prospective longitudinal cohort study of psoriasis patients without arthritis. The patients are assessed annually by a rheumatologist in order to detect the onset of arthritis. We summarize the results of 4 years of followup and report the cumulative incidence of PsA from the time of entry to the study that was estimated using an event per person-years analysis and a nonparametric analysis.
RESULTS: Three hundred thirteen psoriasis patients that had at least 1 year of followup were included in the analysis. The annual incidence rate was found to be 1.87 (95% confidence interval 0.71-3.03) PsA cases per 100 psoriasis patients.
CONCLUSION: The incidence rate of PsA in patients with psoriasis may be higher than previously reported, particularly among patients with moderate to severe psoriasis.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21452273     DOI: 10.1002/acr.20401

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  19 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 2.  Spondyloarthritis with onset after age 45.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Angela Padula; Pietro Leccese; Carlo Palazzi
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

3.  Diagnosis: Screening for arthritis in patients with psoriasis.

Authors:  Oliver FitzGerald
Journal:  Nat Rev Rheumatol       Date:  2012-10-16       Impact factor: 20.543

Review 4.  Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.

Authors:  Alexis Ogdie; J M Gelfand
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

Review 5.  Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.

Authors:  Aisha Q Butt; Angela McArdle; David S Gibson; Oliver FitzGerald; Stephen R Pennington
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

Review 6.  Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations.

Authors:  Éric Toussirot
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

7.  Prevalence and treatment patterns of psoriatic arthritis in the UK.

Authors:  Alexis Ogdie; Sinéad Langan; Thorvardur Love; Kevin Haynes; Daniel Shin; Nicole Seminara; Nehal N Mehta; Andrea Troxel; Hyon Choi; Joel M Gelfand
Journal:  Rheumatology (Oxford)       Date:  2012-12-07       Impact factor: 7.580

8.  Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden.

Authors:  Gail S Kerr; Seema Qaiyumi; John Richards; Hashem Vahabzadeh-Monshie; Chesahna Kindred; Sean Whelton; Florina Constantinescu
Journal:  Clin Rheumatol       Date:  2014-08-28       Impact factor: 2.980

9.  How can psoriatic arthritis be diagnosed early?

Authors:  Amir Haddad; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

10.  Incidence of Psoriatic Arthritis in Patients with Skin Psoriasis and Associated Risk Factors: A Retrospective Population-based Cohort Study in Swedish Routine Clinical Care.

Authors:  Ingrid Lindberg; Mathias Lilja; Kirk Geale; Haijun Tian; Craig Richardson; Amie Scott; Amra Osmancevic
Journal:  Acta Derm Venereol       Date:  2020-11-18       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.